// company-profile
enGene Therapeutics Inc.
ENGNExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.Z4Filings64Insiders28
// api This enGene Therapeutics Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
Recent insider activity is bullish. Over the last 30 days, 9 insiders purchased shares. Buying was led by HASTINGS PAUL J.
// 90-day insight
Over the last 90 days, enGene Therapeutics Inc. insiders bought $0 across 9 transactions with no open-market sales.
- Most active insider: Grossman William with 2 transactions totaling $0.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | HASTINGS PAUL J | ENGN | Award | 31,000 | $0.00 | $0K |
| Jun 16, 2026 | Grossman William | ENGN | Award | 200,000 | $0.00 | $0K |
| Jun 16, 2026 | Joustra Wouter | ENGN | Award | 31,000 | $0.00 | $0K |
| Jun 16, 2026 | Astley-Sparke Philip | ENGN | Award | 31,000 | $0.00 | $0K |
| Jun 16, 2026 | Grossman William | ENGN | Award | 31,000 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.